Stereochemistry | RACEMIC |
Molecular Formula | C12H20N2O4S |
Molecular Weight | 288.363 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)C1=CC=C(O)C(NS(C)(=O)=O)=C1
InChI
InChIKey=HHRNQOGXBRYCHF-UHFFFAOYSA-N
InChI=1S/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3
Molecular Formula | C12H20N2O4S |
Molecular Weight | 288.363 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Soterenol [(+)-1-(3-methanesulphonamido, 4-hydroxyphenyl)-2-isopropylaminoethanol, MJ 1992] is a directly acting sympathomimetic amine which has been shown to display Beta2-adrenoceptor selectivity. Soterenol, a methanesulfonamido-phenethanolamine related structurally to isoproterenol, was a highly effective bronchodilator agent in several animal species by various routes of administration. The bronchodilator potency of soterenol was equivalent to, or greater than, that of isoproterenol. Soterenol also had potent stimulant action on the alpha-receptor of the smooth muscle.
Approval Year
PubMed
Patents
Sample Use Guides
Treatment with soterenol (0.3-300 ug/kg, i.v.) increased the mean arterial blood pressure and decreased heart rate in rabbits.
Route of Administration:
Intravenous